Request for Notification From Industry Organizations Interested in Participating in Selection Process for Nonvoting Industry Representatives on Public Advisory Committees and Request for Nominations for Nonvoting Industry Representatives on Public Advisory Committees, 54589-54590 [E9-25407]
Download as PDF
Federal Register / Vol. 74, No. 203 / Thursday, October 22, 2009 / Notices
Place: Doubletree Hotel Bethesda, 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Lawrence E. Boerboom,
PhD, Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5156,
MSC 7814, Bethesda, MD 20892, (301) 435–
8367, boerboom@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: October 14, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–25405 Filed 10–21–09; 8:45 am]
Contact Person: Ross D. Shonat, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5156,
MSC 7849, Bethesda, MD 20892, 301–435–
2786, shonatr@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: October 15, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–25471 Filed 10–21–09; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Center for Scientific Review; Notice of
Closed Meetings
dcolon on DSK2BSOYB1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; ARRA
AREA Special Emphasis Panel 07.
Date: November 17, 2009.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Beacon Hotel and Corporate
Quarters, 1615 Rhode Island Avenue, NW.,
Washington, DC 20036.
Contact Person: Rolf Menzel, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3196,
MSC 7808, Bethesda, MD 20892, 301–435–
0952, menzelro@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA–OD–
09–008 BRDG–SPAN and RFA–OD–09–009
Catalyst ARRA Review Panel 8.
Date: November 23, 2009.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Fairmont Washington, DC, 2401
M Street, NW., Washington, DC 20037.
15:13 Oct 21, 2009
Jkt 220001
three background papers that will
support the development of NCCAM’s
third strategic plan. Comments may be
provided through the NCCAM Web site
at https://nccam.nih.gov.
For Further Information: To request
more information, visit the NCCAM
Web site at https://nccam.nih.gov, call
1–888–644–6226, or e-mail
Comments Due Date: Comments
regarding the draft of NCCAM’s strategic
plan are best assured of having their full
effect if received by November 19, 2009.
Dated: October 13, 2009.
Jack Killen,
Deputy Director, National Center for
Complementary and Alternative Medicine,
National Institutes of Health.
[FR Doc. E9–25307 Filed 10–21–09; 8:45 am]
BILLING CODE 4140–01–M
National Institutes of Health
National Institutes of Health
VerDate Nov<24>2008
54589
Request for Comment: National Center
for Complementary and Alternative
Medicine Announcement of Strategic
Planning Background Papers
ACTION:
Notice.
The National Center for
Complementary and Alternative
Medicine (NCCAM) is developing its
third strategic plan and invites the
public to provide comments on three
background papers which will support
the development of this plan. The
papers will cover three topics: Mission,
priority setting, and communications
and decisionmaking. They will be
publicly available through the NCCAM
Web site at from on or about October 19
through November 19, 2009. The public
is invited to provide comments through
the NCCAM Web site.
Background: The National Center for
Complementary and Alternative
Medicine (NCCAM) was established in
1998 with the mission of exploring
complementary and alternative healing
practices in the context of rigorous
science, training CAM researchers, and
disseminating authoritative information
to the public and professionals.
To date, NCCAM’s efforts to
rigorously study CAM, to train CAM
researchers, and to communicate with
the public and professionals, have been
guided by NCCAM’s previous strategic
plans, located on the NCCAM Web site
at https://nccam.nih.gov/about/plans.
The public is invited to review the
background papers and provide
comments from October 15 through
November 15, 2009. The papers may be
viewed at https://nccam.nih.gov/.
Request For Comments: The public is
invited to provide comments on the
SUMMARY:
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2009–N–0664]
Request for Notification From Industry
Organizations Interested in
Participating in Selection Process for
Nonvoting Industry Representatives on
Public Advisory Committees and
Request for Nominations for
Nonvoting Industry Representatives on
Public Advisory Committees
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is requesting that
any industry organizations interested in
participating in the selection of
nonvoting industry representatives to
serve on its public advisory committees
for the Center for Food Safety and
Applied Nutrition (CFSAN) notify FDA
in writing. FDA is also requesting
nominations for nonvoting industry
representatives to serve on CFSAN’s
Food Advisory Committee. A nominee
may either be self-nominated or
nominated by an organization to serve
as a nonvoting industry representative.
Nominations will be accepted for
current vacancies effective with this
notice.
DATES: Any industry organization
interested in participating in the
selection of an appropriate nonvoting
member to represent industry interests
must send a letter stating that interest to
FDA by November 23, 2009, for
vacancies listed in this notice.
Concurrently, nomination materials for
E:\FR\FM\22OCN1.SGM
22OCN1
54590
Federal Register / Vol. 74, No. 203 / Thursday, October 22, 2009 / Notices
prospective candidates should be sent to
FDA by November 23, 2009.
ADDRESSES: All letters of interest and
nominations should be submitted in
writing to Carolyn Jeletic (see FOR
FURTHER INFORMATION CONTACT).
FOR FURTHER INFORMATION CONTACT:
Carolyn Jeletic, Center for Food Safety
and Applied Nutrition, Office of
Regulations, Policy, and Social Sciences
(HFS–024), Food and Drug
Administration, 5100 Paint Branch
Pkwy., College Park, MD 20740, 301–
436–1913, carolyn.jeletic@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Selection Procedure
Any industry organization interested
in participating in the selection of an
appropriate nonvoting member to
represent industry interests should send
a letter stating that interest to the FDA
contact (see FOR FURTHER INFORMATION
CONTACT) within 30 days of publication
of this document (see DATES). Within the
subsequent 30 days, FDA will send a
letter to each organization that has
expressed an interest, attaching a
complete list of all such organizations,
and a list of all nominees along with
their current resumes. The letter will
also state that it is the responsibility of
the interested organizations to confer
with one another and to select a
candidate, within 60 days after the
receipt of the FDA letter, to serve as the
nonvoting member to represent industry
interests for a particular committee. The
interested organizations are not bound
by the list of nominees in selecting a
candidate. However, if no individual is
selected within 60 days, the
Commissioner of Food and Drugs will
select the nonvoting member to
represent industry interests.
dcolon on DSK2BSOYB1PROD with NOTICES
II. Application Procedure
Individuals may self nominate and/or
an organization may nominate one or
more individuals to serve as a nonvoting
industry representative. A current
curriculum vitae and the name of the
committee of interest should be sent to
the FDA contact person within the 30
days. FDA will forward all nominations
to the organizations expressing interest
in participating in the selection process
for the committee. (Persons who
nominate themselves as nonvoting
industry representatives will not
participate in the selection process).
FDA has a special interest in ensuring
that women, minority groups,
individuals with physical disabilities,
and small businesses are adequately
represented on its advisory committees,
and therefore, encourages, nominations
for appropriately qualified candidates
VerDate Nov<24>2008
15:13 Oct 21, 2009
Jkt 220001
from these groups. Specifically, in this
document, nominations for nonvoting
representatives of industry interests are
encouraged from the food production
and manufacturing and industry, the
dietary supplement manufacturing
industry, the agricultural biotechnology
manufacturing industry.
This notice is issued under the
Federal Advisory Committee Act (5
U.S.C. app. 2) and 21 CFR part 14,
relating to advisory committees.
Dated: October 16, 2009.
David Horowitz,
Assistant Commissioner for Policy.
[FR Doc. E9–25407 Filed 10–21–09; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
[Docket ID: FEMA–2009–0001]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request, OMB No.
1660–0099
AGENCY: Federal Emergency
Management Agency, DHS.
ACTION: Notice; 30-day notice and
request for comments; revision of a
currently approved information
collection; OMB No. 1660–0099; FEMA
Form 646–0, Citizen Corps Individual
Registration.
SUMMARY: The Federal Emergency
Management Agency (FEMA) has
submitted the information collection
abstracted below to the Office of
Management and Budget for review and
clearance in accordance with the
requirements of the Paperwork
Reduction Act of 1995. The submission
describes the nature of the information
collection, the categories of
respondents, the estimated burden (i.e.,
the time, effort and resources used by
respondents to respond) and cost, and
the actual data collection instruments
FEMA will use.
DATES: Comments must be submitted on
or before November 23, 2009.
ADDRESSES: Submit written comments
on the proposed information collection
to the Office of Information and
Regulatory Affairs, Office of
Management and Budget. Comments
should be addressed to the Desk Officer
for the Department of Homeland
Security, Federal Emergency
Management Agency, and sent via
electronic mail to
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
oira.submission@omb.eop.gov or faxed
to (202) 395–5806.
FOR FURTHER INFORMATION CONTACT:
Requests for additional information or
copies of the information collection
should be made to Director, Office of
Records Management, 1800 South Bell
Street, Arlington, VA 20598–3005,
facsimile number (202) 646–3347, or
e-mail address FEMA–InformationCollections@dhs.gov.
SUPPLEMENTARY INFORMATION:
Collection of Information
Title: Citizen Corps Individual
Registration.
Type of information collection:
Revision of a currently approved
information collection.
OMB Number: OMB No. 1660–0099.
Form Titles and Numbers: FEMA
Form 646–0, Citizen Corps Individual
Registration.
Abstract: FEMA’s Community
Preparedness Division (CPD) would like
to revise a currently approved collection
for its individual registration to allow
members of the public to provide
contact information to receive national
programmatic updates and
announcements such as upcoming
preparedness demonstrations and
training opportunities and the
opportunity to get involved in local
organizations and events.
Affected Public: Individuals or
households.
Estimated Number of Respondents:
20,000.
Frequency of Response: Once.
Estimated Average Hour Burden per
Respondent: .08 burden hours.
Estimated Total Annual Burden
Hours: 1,600 burden hours.
Estimated Cost: None.
Daisy Mitchell,
Acting Director, Records Management
Division, Office of Management, Federal
Emergency Management Agency, Department
of Homeland Security.
[FR Doc. E9–25378 Filed 10–21–09; 8:45 am]
BILLING CODE 9111–05–P
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
[Docket ID: FEMA–2009–0001; OMB No.
1660–0098]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
AGENCY: Federal Emergency
Management Agency, DHS.
E:\FR\FM\22OCN1.SGM
22OCN1
Agencies
[Federal Register Volume 74, Number 203 (Thursday, October 22, 2009)]
[Notices]
[Pages 54589-54590]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-25407]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2009-N-0664]
Request for Notification From Industry Organizations Interested
in Participating in Selection Process for Nonvoting Industry
Representatives on Public Advisory Committees and Request for
Nominations for Nonvoting Industry Representatives on Public Advisory
Committees
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is requesting that any
industry organizations interested in participating in the selection of
nonvoting industry representatives to serve on its public advisory
committees for the Center for Food Safety and Applied Nutrition (CFSAN)
notify FDA in writing. FDA is also requesting nominations for nonvoting
industry representatives to serve on CFSAN's Food Advisory Committee. A
nominee may either be self-nominated or nominated by an organization to
serve as a nonvoting industry representative. Nominations will be
accepted for current vacancies effective with this notice.
DATES: Any industry organization interested in participating in the
selection of an appropriate nonvoting member to represent industry
interests must send a letter stating that interest to FDA by November
23, 2009, for vacancies listed in this notice. Concurrently, nomination
materials for
[[Page 54590]]
prospective candidates should be sent to FDA by November 23, 2009.
ADDRESSES: All letters of interest and nominations should be submitted
in writing to Carolyn Jeletic (see FOR FURTHER INFORMATION CONTACT).
FOR FURTHER INFORMATION CONTACT: Carolyn Jeletic, Center for Food
Safety and Applied Nutrition, Office of Regulations, Policy, and Social
Sciences (HFS-024), Food and Drug Administration, 5100 Paint Branch
Pkwy., College Park, MD 20740, 301-436-1913,
carolyn.jeletic@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Selection Procedure
Any industry organization interested in participating in the
selection of an appropriate nonvoting member to represent industry
interests should send a letter stating that interest to the FDA contact
(see FOR FURTHER INFORMATION CONTACT) within 30 days of publication of
this document (see DATES). Within the subsequent 30 days, FDA will send
a letter to each organization that has expressed an interest, attaching
a complete list of all such organizations, and a list of all nominees
along with their current resumes. The letter will also state that it is
the responsibility of the interested organizations to confer with one
another and to select a candidate, within 60 days after the receipt of
the FDA letter, to serve as the nonvoting member to represent industry
interests for a particular committee. The interested organizations are
not bound by the list of nominees in selecting a candidate. However, if
no individual is selected within 60 days, the Commissioner of Food and
Drugs will select the nonvoting member to represent industry interests.
II. Application Procedure
Individuals may self nominate and/or an organization may nominate
one or more individuals to serve as a nonvoting industry
representative. A current curriculum vitae and the name of the
committee of interest should be sent to the FDA contact person within
the 30 days. FDA will forward all nominations to the organizations
expressing interest in participating in the selection process for the
committee. (Persons who nominate themselves as nonvoting industry
representatives will not participate in the selection process).
FDA has a special interest in ensuring that women, minority groups,
individuals with physical disabilities, and small businesses are
adequately represented on its advisory committees, and therefore,
encourages, nominations for appropriately qualified candidates from
these groups. Specifically, in this document, nominations for nonvoting
representatives of industry interests are encouraged from the food
production and manufacturing and industry, the dietary supplement
manufacturing industry, the agricultural biotechnology manufacturing
industry.
This notice is issued under the Federal Advisory Committee Act (5
U.S.C. app. 2) and 21 CFR part 14, relating to advisory committees.
Dated: October 16, 2009.
David Horowitz,
Assistant Commissioner for Policy.
[FR Doc. E9-25407 Filed 10-21-09; 8:45 am]
BILLING CODE 4160-01-S